|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.11/-0.11
|
企业价值
48.87M
|
资产负债 |
每股账面净值
0.08
|
现金流量 |
现金流量率
--
|
损益表 |
收益
1.10M
|
每股收益
0.01
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/03 21:06 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. |